New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.

New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.

Item
http://www.wikidata.org/entity/Q36189400
Restricting the induction of NGF in ovarian stroma engenders selective follicular activation through the mTOR signaling pathway.Multiple Mechanisms Cooperate to Constitutively Exclude the Transcriptional Co-Activator YAP from the Nucleus During Murine Oogenesis.Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood.Dormancy and activation of human oocytes from primordial and primary follicles: molecular clues to oocyte regulation.In Vitro Activation: A Possible New Frontier for Treatment of Primary Ovarian Insufficiency.Activation of dormant follicles: a new treatment for premature ovarian failure?Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome.Improving oocyte quality by transfer of autologous mitochondria from fully grown oocytes.Understanding follicle growth in vitro: Are we getting closer to obtaining mature oocytes from in vitro-grown follicles in human?mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.Inhibition of mTOR Signaling Pathway Delays Follicle Formation in Mice.The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development.Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure
P2860

New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.

Item
http://www.wikidata.org/entity/Q36189400
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@ast
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@en
type
label
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@ast
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@en
prefLabel
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@ast
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
New strategy for in vitro acti ...... ith mTOR and PI3K stimulators.
@en
P2093
P2860
P304
P31
P356
10.1080/15384101.2014.995496
P433
P478
P577
P698
P932